Physician resources

Phexx 101

Useful information about Phexx.

Sample Letter of Medical Necessity

A form for you to send to your patient's insurance company to obtain Phexx with no restrictions or out-of-pocket cost.

Have a Question About Phexx?

See answers to frequently asked questions.

Contraceptive Counseling Chart

Help your patients decide which birth control method meets their needs.

Phexx Mechanism of Action
A video that demonstrates the MOA of Phexx.

Contact an Evofem Representative Contact an Evofem Representative

Contact an Evofem Representative

Schedule an in-person or online detail with an Evofem Representative to learn more about Phexx.

Patient resources

Patient Brochure

Essential information for women who are prescribed or are considering Phexx.

Patient Information

Information for women who are prescribed Phexx.

Instructions for Use Flashcard

A flashcard that provides women step-by-step instructions on how to correctly use Phexx.

Instructions for Use Video
A video that provides instructions for correct use.

Watch this video to see instructions for the correct use of Phexx. You can also share this video with your patients so they understand how to use Phexx.

INDICATION

Phexx is indicated for the prevention of pregnancy in females of reproductive potential for use as an on-demand method of contraception.

LIMITATIONS OF USE

Phexx is not effective for the prevention of pregnancy when administered after intercourse.

IMPORTANT SAFETY INFORMATION

WARNINGS AND PRECAUTIONS

Few cases (0.36%) of adverse reactions of cystitis, pyelonephritis and other upper urinary tract infection (UTI) have been reported in Phexx clinical studies. Of these, one case of pyelonephritis was considered serious and required hospitalization. Avoid use of Phexx in females with history of recurrent urinary tract infection or urinary tract abnormalities.

ADVERSE REACTIONS

Most common adverse reactions were vulvovaginal burning sensation, pruritus, mycotic infection, genital discomfort (including male partners); urinary tract infection, bacterial vaginosis, vaginal discharge, and dysuria. Patients should consult their healthcare provider for severe or prolonged genital irritation or urinary tract symptoms.

Advise the patient:

  • To discontinue Phexx if they develop a local hypersensitivity reaction.
  • That Phexx does not protect against HIV infection or other sexually transmitted infections.
  • Avoid Phexx use with vaginal rings.

To report SUSPECTED ADVERSE REACTIONS, contact Evofem at toll-free phone 1-833-EVFMBIO or you may contact FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Please see full Prescribing Information for Phexx.

IMPORTANT SAFETY INFORMATION

WARNINGS AND PRECAUTIONS

Few cases (0.36%) of adverse reactions of cystitis, pyelonephritis and other upper urinary tract infection (UTI) have been reported in Phexx clinical studies. Of these, one case of pyelonephritis was considered serious and required hospitalization. Avoid use of Phexx in females with history of recurrent urinary tract infection or urinary tract abnormalities.

ADVERSE REACTIONS

Most common adverse reactions were vulvovaginal burning sensation, pruritus, mycotic infection, genital discomfort (including male partners); urinary tract infection, bacterial vaginosis, vaginal discharge, and dysuria. Patients should consult their healthcare provider for severe or prolonged genital irritation or urinary tract symptoms.

Advise the patient:

  • To discontinue Phexx if they develop a local hypersensitivity reaction.
  • That Phexx does not protect against HIV infection or other sexually transmitted infections.
  • Avoid Phexx use with vaginal rings.

To report SUSPECTED ADVERSE REACTIONS, contact Evofem at toll-free phone 1-833-EVFMBIO or you may contact FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Please see full Prescribing Information for Phexx.

INDICATION

Phexx is indicated for the prevention of pregnancy in females of reproductive potential for use as an on-demand method of contraception.

LIMITATIONS OF USE

Phexx is not effective for the prevention of pregnancy when administered after intercourse.